Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Granulocyte products: The saga continues.
Klinkmann G, Goudeva L, Blasczyk R, Mitzner S, Altrichter J. Klinkmann G, et al. Among authors: goudeva l. Transfusion. 2023 Apr;63(4):894-896. doi: 10.1111/trf.17291. Transfusion. 2023. PMID: 37038735 No abstract available.
Asymmetric dimethylarginine is an independent risk factor for coronary heart disease: results from the multicenter Coronary Artery Risk Determination investigating the Influence of ADMA Concentration (CARDIAC) study.
Schulze F, Lenzen H, Hanefeld C, Bartling A, Osterziel KJ, Goudeva L, Schmidt-Lucke C, Kusus M, Maas R, Schwedhelm E, Strödter D, Simon BC, Mügge A, Daniel WG, Tillmanns H, Maisch B, Streichert T, Böger RH. Schulze F, et al. Among authors: goudeva l. Am Heart J. 2006 Sep;152(3):493.e1-8. doi: 10.1016/j.ahj.2006.06.005. Am Heart J. 2006. PMID: 16923419
Semaphorin 7A inhibits platelet production from CD34+ progenitor cells.
Jaimes Y, Gras C, Goudeva L, Buchholz S, Eiz-Vesper B, Seltsam A, Immenschuh S, Blasczyk R, Figueiredo C. Jaimes Y, et al. Among authors: goudeva l. J Thromb Haemost. 2012 Jun;10(6):1100-8. doi: 10.1111/j.1538-7836.2012.04708.x. J Thromb Haemost. 2012. PMID: 22448926 Free article.
CMV-, EBV- and ADV-specific T cell immunity: screening and monitoring of potential third-party donors to improve post-transplantation outcome.
Sukdolak C, Tischer S, Dieks D, Figueiredo C, Goudeva L, Heuft HG, Verboom M, Immenschuh S, Heim A, Borchers S, Mischak-Weissinger E, Blasczyk R, Maecker-Kolhoff B, Eiz-Vesper B. Sukdolak C, et al. Among authors: goudeva l. Biol Blood Marrow Transplant. 2013 Oct;19(10):1480-92. doi: 10.1016/j.bbmt.2013.07.015. Epub 2013 Jul 23. Biol Blood Marrow Transplant. 2013. PMID: 23891747 Free article.
44 results